Should I Buy IMMP? IMMP 2026 Analysis

Should You Buy Immutep Ltd (IMMP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

2.800

1 Day change

1.08%

52 Week Range

3.530

Analysis Updated At

2026/02/13

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Immutep Ltd (IMMP) does not present a compelling buy opportunity for a beginner, long-term investor at this moment. The technical indicators are neutral, there are no significant trading trends or positive catalysts, and the options data does not suggest strong bullish sentiment. Additionally, there is no recent financial data or news to support a strong investment case. Given the lack of positive momentum and the user's preference for long-term investing, holding off for now is recommended.

Technical Analysis

The MACD histogram is -0.0336, below 0, and negatively contracting, indicating weak momentum. RSI is at 43.282, in the neutral zone, suggesting no clear trend. Moving averages are converging, and the stock is trading near its pivot level (2.757), with resistance at 2.913 and support at 2.6. Overall, the technical indicators are neutral.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

The implied volatility is extremely high (871.2), with an IV percentile of 100 and IV rank of 101.56, indicating significant uncertainty. However, the put-call ratios and low option volume suggest limited bullish sentiment.

Technical Summary

Sell

Buy

Positive Catalysts

NULL identified. No recent news, significant trading trends, or influential figure activity.

Neutral/Negative Catalysts

and lack of positive trading sentiment. No recent financial data or news to support growth.

Financial Performance

No financial data available for analysis. Latest quarter financials could not be assessed due to missing data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes available for evaluation.

1 Analyst Rating

Wall Street analysts forecast IMMP stock price to rise

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 2.770

Low

Averages

High

Current: 2.770

Low

Averages

High

Citizens

Outperform

initiated

AI Analysis

2026-02-17

New

Reason

Citizens

Price Target

AI Analysis

2026-02-17

New

initiated

Outperform

Reason

Citizens initiated coverage of Immutep with an Outperform rating and $6 price target. The firm says the company's eftilagimod alpha has demonstrated "strong" clinical immunostimulatory effects that potentiate and expand the effectiveness of established checkpoint inhibitor therapies across multiple large Phase 2 studies. Citizens believes Immutep shares represent an "attractive investment opportunity," with 62% potential downside in a bear case and 279% potential upside in a bull case.

IMMP Should I Buy

IMMP Should I Buy

Should You Buy Immutep Ltd (IMMP) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch